Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6570)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2019 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Liang JH, Lin Y, Ouyang T, Tang W, Huang Y, Ye W, Zhao JY, Wang ZN, Ma CC. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine. World J Gastroenterol 2019; 25(25): 3218-3230 [PMID: 31333313 DOI: 10.3748/wjg.v25.i25.3218] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i25/3218.htm |
| Number | Citing Articles |
| 1 |
Jinhui Zhao, Xinshu Zhao, Jiaying Yu, Siqi Gao, Mingjia Zhang, Tongshu Yang, Liyan Liu. A multi-platform metabolomics reveals possible biomarkers for the early-stage esophageal squamous cell carcinoma. Analytica Chimica Acta 2022; 1220: 340038 doi: 10.1016/j.aca.2022.340038
|
| 2 |
Yan Zhao, Changchun Ma, Rongzhi Cai, Lijing Xin, Yongsheng Li, Lixin Ke, Wei Ye, Ting Ouyang, Jiahao Liang, Renhua Wu, Yan Lin. NMR and MS reveal characteristic metabolome atlas and optimize esophageal squamous cell carcinoma early detection. Nature Communications 2024; 15(1) doi: 10.1038/s41467-024-46837-0
|
| 3 |
Bin Zang, Wen Wang, Yiqian Wang, Pengfei Li, Tian Xia, Xiaolong Liu, Di Chen, Hai-long Piao, Huan Qi, Yegang Ma. Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.721990
|
| 4 |
Katherine Huang, Natalie Thomas, Paul R. Gooley, Christopher W. Armstrong. Systematic Review of NMR-Based Metabolomics Practices in Human Disease Research. Metabolites 2022; 12(10): 963 doi: 10.3390/metabo12100963
|
| 5 |
Marie-France Penet, Zaver M. Bhujwalla. Encyclopedia of Biophysics. 2022; : 1 doi: 10.1007/978-3-642-35943-9_10097-1
|
| 6 |
Wei Ye, Yan Lin, Tedros Bezabeh, Changchun Ma, Jiahao Liang, Jiayun Zhao, Ting Ouyang, Wan Tang, Renhua Wu. 1H NMR‐based metabolomics of paired esophageal tumor tissues and serum samples identifies specific serum biomarkers for esophageal cancer. NMR in Biomedicine 2021; 34(6) doi: 10.1002/nbm.4505
|
| 7 |
Marie‐France Penet, Raj Kumar Sharma, Santosh Bharti, Noriko Mori, Dmitri Artemov, Zaver M. Bhujwalla. Cancer insights from magnetic resonance spectroscopy of cells and excised tumors. NMR in Biomedicine 2023; 36(4) doi: 10.1002/nbm.4724
|
| 8 |
Yunjie Li, Fengqiong Hu, Jie Deng, Xin Huang, Chunyan Zhou, Mengxue Wu, Dong Duan. Proteomic analysis of radioiodine‑refractory differentiated thyroid cancer identifies CHI3L1 upregulation in association with dysfunction of the sodium‑iodine symporter. Oncology Letters 2022; 25(1) doi: 10.3892/ol.2022.13622
|
| 9 |
Yanling Sun, Xinchang Zheng, Guoliang Wang, Yibo Wang, Xiaoning Chen, Jiani Sun, Zhuang Xiong, Sisi Zhang, Tianyi Wang, Zhuojing Fan, Congfan Bu, Yiming Bao, Wenming Zhao. MACdb: A Curated Knowledgebase for Metabolic Associations across Human Cancers. Molecular Cancer Research 2023; 21(7): 691 doi: 10.1158/1541-7786.MCR-22-0909
|
| 10 |
Susan Costantini, Alfredo Budillon. Metabolomics Perspectives. 2022; : 553 doi: 10.1016/B978-0-323-85062-9.00016-7
|
| 11 |
Ting Ouyang, Changchun Ma, Yan Zhao, Wei Ye, Jiayun Zhao, Rongzhi Cai, Huanian Zhang, Peie Zheng, Yan Lin. 1H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1082841
|